We are using cookies to give you the best experience. You can find out more about which cookies we are using or switch them off in privacy settings.
AcceptPrivacy Settings

Johnson & Johnson (J&J) COVID-19 Vaccine Update April 30, 2021

Last week, the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) lifted the temporary recommended pause of use on the Johnson & Johnson (J&J) COVID-19 vaccine. The Pennsylvania Department of Health has also advised vaccine providers that they can resume use of the J&J vaccine in Pennsylvania.

We recognize that there may be some concern and hesitancy specifically towards the J&J vaccine now that it is available again, and we’d like to share a bit of information to help you weigh your options regarding the vaccines available.

By recommending that the country resume using the J&J vaccine, the CDC and FDA are affirming the J&J vaccine’s overall safety. The agencies’ joint statement on the return is available at fda.gov, but we would like to highlight a few points. Read more.

GDPR

  • Google Analytics

Google Analytics

This website uses Google Analytics to collect anonymous information, including the number of visitors and most popular pages.

Keeping this cookie enabled helps us to continually improve our site.